Evidence map›Paper›PMID 35681523›Full record

ReviewCells2022

Breakthroughs and Applications of Organ-on-a-Chip Technology.

Mufeeda C Koyilot, Priyadarshini Natarajan, Clayton R Hunt, Sonish Sivarajkumar, Romy Roy, Shreeram Joglekar, Shruti Pandita, Carl W Tong, Shamsudheen Marakkar, Lakshminarayanan Subramanian and 5 more

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 95 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Lessons Learned from Liver-on-Chip Platform.Annals of biomedical engineering · 2025
    Review
  14. Review
  15. Advances in Microfluidic Cochlea-On-A-Chip.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  16. Review
  17. Engineering in vitro vascular microsystems.Microsystems & nanoengineering · 2025
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 2 countries.

Mufeeda C KoyilotMolecular Robotics, Cochin 682033, India.
Priyadarshini NatarajanMolecular Robotics, Cochin 682033, India.ORCID 0000-0002-6199-5991
Clayton R HuntHouston Methodist Research Institute, Houston, TX 77030, USA.
Sonish SivarajkumarMolecular Robotics, Cochin 682033, India.
Romy RoyMolecular Robotics, Cochin 682033, India.ORCID 0000-0001-6310-5633
Shreeram JoglekarMolecular Robotics, Cochin 682033, India.ORCID 0000-0002-8215-805X
Shruti PanditaMays Cancer Center, University of Texas Health Sciences Center at San Antonio, San Antonio, TX 78229, USA.
Carl W TongSchool of Engineering Medicine, Texas A&M University, Houston, TX 77030, USA.
Shamsudheen MarakkarMolecular Robotics, Cochin 682033, India.ORCID 0000-0002-9321-0407
Lakshminarayanan SubramanianCourant Institute of Mathematical Science, New York University, New York, NY 10012, USA.
Shalini S YadavDepartment of Immunology, UT MD Anderson Cancer Center, Houston, TX 77030, USA.
Anoop V CherianMolecular Robotics, Cochin 682033, India.
Tej K PanditaHouston Methodist Research Institute, Houston, TX 77030, USA.ORCID 0000-0002-2365-5937
Khader ShameerSchool of Public Health, Faculty of Medicine, Imperial College London, South Kensington, London SW7 2AZ, UK.
Kamlesh K YadavSchool of Engineering Medicine, Texas A&M University, Houston, TX 77030, USA.
Houston Methodist · USTexas A&M University · USCourant Institute of Mathematical Sciences · USImperial College London · GBThe University of Texas Health Science Center at San Antonio · USThe University of Texas MD Anderson Cancer Center · US

Funding

Cardiac Myosin Binding Protein-C in Development and Reversal of Heart FailureR01HL145534 · NHLBI · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI TONG, CARL WEI-CHAN · 2019 to 2023
$2.4M
NHLBI NIH HHS R01 HL145534
6 · The paper itself

Abstract

Organ-on-a-chip (OOAC) is an emerging technology based on microfluid platforms and in vitro cell culture that has a promising future in the healthcare industry. The numerous advantages of OOAC over conventional systems make it highly popular. The chip is an innovative combination of novel technologies, including lab-on-a-chip, microfluidics, biomaterials, and tissue engineering. This paper begins by analyzing the need for the development of OOAC followed by a brief introduction to the technology. Later sections discuss and review the various types of OOACs and the fabrication materials used. The implementation of artificial intelligence in the system makes it more advanced, thereby helping to provide a more accurate diagnosis as well as convenient data management. We introduce selected OOAC projects, including applications to organ/disease modelling, pharmacology, personalized medicine, and dentistry. Finally, we point out certain challenges that need to be surmounted in order to further develop and upgrade the current systems.

Indexed as

Artificial IntelligenceLab-On-A-Chip DevicesBiocompatible MaterialsMicrofluidicsTissue EngineeringBiocompatible Materialsheartkidneyliverlungorgan-on-a-chiptechnology

Identifiers

PMID35681523
PMCPMC9180073
OpenAlexW4281946781

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.